Goldstein M - Search Results

1

The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes.

Goldstein M, Lieberman AN, Takasugi N, Shimizu Y, Kuga S. Goldstein M, et al. Adv Neurol. 1990;53:101-6. Adv Neurol. 1990. PMID: 1978511 Review. No abstract available.

2

Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.

Lieberman AN, Gopinathan G, Pasternack P, Goldstein M. Lieberman AN, et al. Among authors: goldstein m. Adv Neurol. 1990;53:533-7. Adv Neurol. 1990. PMID: 1978521 Clinical Trial. No abstract available.

3

D-1 and D-2 agonists in Parkinson's disease.

Lieberman AN, Goldstein M, Gopinathan G, Neophytides A. Lieberman AN, et al. Among authors: goldstein m. Can J Neurol Sci. 1987 Aug;14(3 Suppl):466-73. doi: 10.1017/s0317167100037938. Can J Neurol Sci. 1987. PMID: 2960431 Review.

4

The antiparkinsonian efficacy of bromocriptine.

Lieberman A, Zolfaghari M, Boal D, Hassouri H, Vogel B, Battista A, Fuxe K, Goldstein M. Lieberman A, et al. Among authors: goldstein m. Neurology. 1976 May;26(5):405-9. doi: 10.1212/wnl.26.5.405. Neurology. 1976. PMID: 817221

5

The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease.

Goldstein M, Lieberman A. Goldstein M, et al. Neurology. 1992 Apr;42(4 Suppl 4):8-12; discussion 41-8. Neurology. 1992. PMID: 1350074 Review.

6

Adrenal medullary transplants as a treatment for Parkinson's disease.

Lieberman A, Ransohoff J, Berczeller P, Brous P, Eng K, Goldstein M, Kaufman B, Koslow M, Lieberman I. Lieberman A, et al. Among authors: goldstein m. Adv Neurol. 1990;53:567-70. Adv Neurol. 1990. PMID: 2239497 No abstract available.

7

Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients.

Goldstein M, Lieberman AN, Helmer E, Koslow M, Ransohoff J, Elsworth JD, Roth RH, Deutch AY. Goldstein M, et al. Ann Neurol. 1988 Nov;24(5):685-8. doi: 10.1002/ana.410240517. Ann Neurol. 1988. PMID: 2904793

8

The pathophysiological functions mediated by D1 dopamine receptors.

Goldstein M, Kuga S, Shimizu Y, Meller E. Goldstein M, et al. Adv Exp Med Biol. 1986;204:189-95. doi: 10.1007/978-1-4684-5191-7_12. Adv Exp Med Biol. 1986. PMID: 2947428

9

Pergolide and lisuride in advanced Parkinson's disease.

Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Goldstein M. Lieberman AN, et al. Among authors: goldstein m. Adv Neurol. 1984;40:503-7. Adv Neurol. 1984. PMID: 6695627

10

Studies on the antiparkinsonism efficacy of lergotrile.

Lieberman A, Miyamoto T, Battista AF, Goldstein M. Lieberman A, et al. Among authors: goldstein m. Neurology. 1975 May;25(5):459-62. doi: 10.1212/wnl.25.5.459. Neurology. 1975. PMID: 166332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,640 results

Search Page

Filters